Mesenchymal stem cell-derived exosomes for treatment of sepsis is a research paper published in Frontiers in Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 29 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: R01 GM097480
NHLBI NIH HHS
Grant: R01 HL113022
NHLBI NIH HHS
Grant: R01 HL148781
National Institutes of Health
Grant: 5R01GM097480-09
Etiology of Microvascular Changes in Gram-positive Sepsis: Mechanisms and Therapeutic Options
National Institutes of Health
Grant: 5R01HL113022-04
Human mesenchymal stem cell microvesicles for the treatment of acute lung injury
National Institutes of Health
Grant: 1R01HL148781-01A1
Therapeutic Use of High Molecular Weight Hyaluronic Acid in Acute Lung Injury Following Severe Bacterial Pneumonia or Sepsis
FWCI
2.66
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals